Table 3.
Use of Additional Medications (N = 105)
| Medication Class | Patients |
|---|---|
| SU | 18 (17.1) |
| DPP-4 inhibitor | 6 (5.7) |
| Metformin | 78 (74.3) |
| SGLT2 inhibitor | 11 (10.5) |
| GLP-1 receptor agonist | 37 (35.2) |
Data are n (%).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.